Copeptin: a neuroendocrine biomarker of COVID-19 severity-Reference-Cited by-同舟云学术

Copeptin: a neuroendocrine biomarker of COVID-19 severity

Published:2022-06 Issue:8 Volume:16 Page:589-597
ISSN:1752-0363
Container-title:Biomarkers in Medicine
language:en
Short-container-title:Biomarkers in Medicine

Author:

Hammad Reham¹^ORCID,Elshafei Ahmed²^ORCID,Khidr Emad Gamil²^ORCID,El-Husseiny Ahmed A²^ORCID,Gomaa Maher H²^ORCID,Kotb Hend G³^ORCID,Eltrawy Heba H⁴^ORCID,Farhoud Hesham⁵

Affiliation:

1. Department of Clinical Pathology, Faculty of Medicine (Girls), Al-Azhar University, Cairo, 11884, Egypt

2. Biochemistry & Molecular Biology Department, Faculty of Pharmacy (Boys), Al-Azhar University, Cairo, 11884, Egypt

3. Internal Medicine Department, Faculty of Medicine (Girls), Al-Azhar University, Cairo, 11884, Egypt

4. Chest Diseases Department, Faculty of Medicine (Girls), Al-Azhar University, Cairo, 11884, Egypt

5. Orthopedic Surgery Department, Dean of Faculty of Medicine (Girls), Al-Azhar University, Cairo, 11884, Egypt

Abstract

Aim: To investigate the change in a serum level of copeptin, a neuroendocrine biomarker, in differentiating grades of COVID-19 severity on admission time and to find its diagnostic potential. Materials & Methods: 160 COVID-19 patients were classified according to disease severity into 80 mild to moderate and 80 severe patients. Serum copeptin level was assessed by ELISA on their admission time. Besides, serum CRP, ferritin and D-dimer were estimated. Results: Severe COVID-19 patients showed higher serum copeptin level in comparison to mild to moderate cases, with diagnostic potential to distinguish disease severity with 93.33% sensitivity and 100% specificity at cutoff value >18.5 Pmol/l. Conclusion: Serum copeptin was remarkably increased with COVID-19 severity with reasonable differentiation potential for recently admitted patients.

Publisher

Future Medicine Ltd

Subject

Biochemistry (medical),Clinical Biochemistry,Drug Discovery

Link

https://www.futuremedicine.com/doi/pdf/10.2217/bmm-2021-1100

Reference45 articles.

1. RAAS, ACE2 and COVID-19; a mechanistic review

2. COVID-19 pandemic – an African perspective

3. The first and second waves of the COVID-19 pandemic in Africa: a cross-sectional study

4. Correlation analysis between disease severity and clinical and biochemical characteristics of 143 cases of COVID-19 in Wuhan, China: a descriptive study

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The Potential Role of Hypothalamic Phospholipid Liposomes in the Supportive Therapy of Some Manifestations of Post-COVID-19 Condition: Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS) and Brain Fog;Journal of Clinical Medicine;2023-08-23

2. Copeptin: Up-to-date diagnostic and prognostic role highlight;Analytical Biochemistry;2023-07

3. Relevance of TMPRSS2, CD163/CD206, and CD33 in clinical severity stratification of COVID-19;Frontiers in Immunology;2023-03-08

4. RETRACTED ARTICLE: Review novel insights into the diagnostic and prognostic function of copeptin in daily clinical practice;Molecular Biology Reports;2023-01-20

5. Mutations in SARS-CoV-2: Insights on structure, variants, vaccines, and biomedical interventions;Biomedicine & Pharmacotherapy;2023-01